Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Heparan sulfate
Drug ID BADD_D01059
Description Not Available
Indications and Usage Not Available
Marketing Status Not Available
ATC Code Not Available
DrugBank ID Not Available
KEGG ID D08536
MeSH ID D006497
PubChem ID Not Available
TTD Drug ID D0A1QC
NDC Product Code Not Available
UNII Not Available
Synonyms Heparitin Sulfate | Sulfate, Heparitin | Heparan Sulfate | Sulfate, Heparan
Chemical Information
Molecular Formula Not Available
CAS Registry Number Not Available
SMILES Not Available
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Adrenal haemorrhage12.01.17.003; 24.07.01.023; 05.01.03.002--Not Available
Adrenocortical insufficiency acute14.11.01.020; 05.01.02.005--Not Available
Alopecia23.02.02.001--
Anaphylactic shock10.01.07.002; 24.06.02.004--Not Available
Anaphylactoid reaction24.06.03.007; 10.01.07.003--Not Available
Asthma22.03.01.002; 10.01.03.010--Not Available
Body temperature increased13.15.01.001--Not Available
Cardiac failure congestive02.05.01.002--Not Available
Cerebrovascular accident17.08.01.007; 24.03.05.001--
Chills15.05.03.016; 08.01.09.001--
Coagulation time prolonged13.01.02.006--Not Available
Cyanosis23.06.04.005; 02.11.04.004; 24.03.01.007; 22.02.02.007--
Erythema23.03.06.001--Not Available
Extravasation08.01.03.008--Not Available
Fluid retention20.01.02.003; 14.05.06.002--Not Available
Gangrene24.04.05.003; 11.02.01.003; 23.06.06.001--Not Available
Haematoma24.07.01.001--
Haemoglobin13.01.05.018--Not Available
Headache17.14.01.001--
Hypernatraemia14.05.04.001--
Hypersensitivity10.01.03.003--
Hypervolaemia02.05.04.019; 14.05.06.003--Not Available
Infection11.01.08.002--Not Available
Injection site irritation12.07.03.027; 08.02.03.027--Not Available
Lacrimation increased06.08.02.004--
Myocardial infarction24.04.04.009; 02.02.02.007--
Nausea07.01.07.001--
Necrosis24.04.02.006; 08.03.03.001--Not Available
Oedema14.05.06.010; 08.01.07.006--Not Available
Osteoporosis14.04.04.002; 15.02.03.002--
The 1th Page    1 2    Next   Last    Total 2 Pages